May 26, 2022
5 min watch
Save
VIDEO: Jaffe discusses GATHER1 trial for geographic atrophy treatment
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, Glenn J. Jaffe, MD, discusses a post hoc analysis of the GATHER1 trial of geographic atrophy lesion growth.
Published by:
Sources/Disclosures
Collapse
Source:
Jaffe G. Evaluation of GA lesion growth by minimum distance to the fovea center: Post hoc analysis of the GATHER1 trial. Presented at: Retina World Congress; May 12-15, 2022; Fort Lauderdale, Fla.
Disclosures:
Jaffe reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.